Microsoft PowerPoint - TVD2017_Intro_VK_ws_final.pptx

Previous Page

Next Page

Page Background

PC: Hypofractionation

CHHiP (N=3216): T1b-T3a N0M0. PSA ≤30, LN risk

≤30%, Medium FU 62m

Dearnaley et al Lanc Oncol 2016

Trial Endpoint: Non-Inferiority Outcome